30.61USD-0.52%Mkt Cap: 1.90B USDP/E: —Last update: 2026-06-01
Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.90B USD
Enterprise Value1.59B USD
Revenue (TTM)32.08M USD
Gross Profit32.08M USD
Net Income (TTM)-6.88M USD
Revenue/Share0.5300 USD
Last Price30.61 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees170
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS86150R1077
Valuation
P/E (Trailing)—
P/E (Forward)-9.96
PEG—
EV/EBITDA-8.64
EV/Revenue49.41
P/S60.01
P/B4.87
EPS (TTM)-2.86
EPS (Forward)-3.10
52W Range
9.36069% of range40.22
52W High40.22 USD
52W Low9.360 USD
Profitability
Gross Margin100.00%
Oper. Margin-857.57%
EBITDA Margin0.00%
Profit Margin-3.73%
ROE-1.95%
ROA-1.65%
Growth
Revenue Growth-96.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF45.59M USD
CapEx (TTM)670.00K USD
FCF Margin-276.45%
FCF Yield-4.67%
Net Debt-340.12M USD
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity0.01
Current Ratio8.99
Quick Ratio8.57
Book Value/Sh6.344 USD
Cash/Share5.516 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)45.10 USD
Target Range35.00 USD – 60.00 USD
# Analysts10
Ownership
Shares Out.62.28M
Float46.76M
Insiders3.82%
Institutions120.35%
Short Interest
Short Ratio25.9d
Short % Float21.57%
Short % Out.20.74%
Shares Short12.92M
Short (prev mo.)12.54M
Technical
SMA 5033.03 (-7.3%)
SMA 20029.99 (+2.1%)
Beta1.20
S&P 52W Chg27.70%
Avg Vol (30d)488.10K
Avg Vol (10d)601.23K
Technical Indicators
RSI (14)43.9
MACD-0.7912
MACD Signal-0.8935
MACD Hist.+0.1023
BB Upper34.50 USD
BB Middle31.53 USD
BB Lower28.57 USD
BB Width18.81%
ATR (14)1.549 USD
Vol Ratio (20d)0.41x